1-3 of 3
Naomi Kawashima, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FF-10101 Retains Potent Inhibitory Activities Against Resistant Mutations to FLT3 Inhibitors, Newly Identified in Random Mutagenesis Screens

Yuichi Ishikawa, MD PhD, Koichi Saito, PhD, Naomi Kawashima, MD PhD, Michie Morimoto, Hidetoshi Murao, PhD, Daisuke Terada, Takeshi Yamaura, Shinji Hagiwara, PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2672.
https://doi.org/10.1182/blood-2019-124632
Published: 2019
Journal Articles

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

Naomi Kawashima, MD PhD, Yuichi Ishikawa, MD PhD, Yoshiko Atsuta, MD PhD, Masashi Sawa, MD PhD, Yukiyasu Ozawa, MD PhD, Masaki Hayashi, MD, Akio Kohno, MD PhD, Akihiro Tomita, MD PhD, Tomoya Maeda, MD PhD, Emiko Sakaida, MD PhD, Kensuke Usuki, MD PhD, Maki Hagihara, MD PhD, Heiwa Kanamori, MD PhD, Hiroshi Matsuoka, MD PhD, Miki Kobayashi, MD PhD, Norio Asou, MD PhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1328.
https://doi.org/10.1182/blood-2019-124394
Published: 2019
Journal Articles

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

Jeong Hui Kim, Yasuhiko Harada, MD PhD, Yuichi Ishikawa, MD PhD, Naomi Kawashima, MD PhD, Marie Nakashima, MD, Yoko Ushijima, MD PhD, Takahiro Nishiyama, MD PhD, Tatsunori Goto, MD PhD, Nobuaki Fukushima, MD PhD, Rika Kihara, MD PhD, Tomohiro Kajiguchi, MD PhD, Koichi Watamoto, MD PhD, Akio Kohno, MD PhD, Kunio Kitamura, MD PhD, Yukiyasu Ozawa, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1418.
https://doi.org/10.1182/blood-2019-127610
Published: 2019